These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21297277)

  • 21. Neuroprotective effect of 3,5-di-O-caffeoylquinic acid on SH-SY5Y cells and senescence-accelerated-prone mice 8 through the up-regulation of phosphoglycerate kinase-1.
    Han J; Miyamae Y; Shigemori H; Isoda H
    Neuroscience; 2010 Sep; 169(3):1039-45. PubMed ID: 20570715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A vaccine with Aβ oligomer-specific mimotope attenuates cognitive deficits and brain pathologies in transgenic mice with Alzheimer's disease.
    Wang SW; Liu DQ; Zhang LX; Ji M; Zhang YX; Dong QX; Liu SY; Xie XX; Liu RT
    Alzheimers Res Ther; 2017 Jun; 9(1):41. PubMed ID: 28592267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of the shortest Aβ-peptide generating highly specific antibodies against the C-terminal end of amyloid-β42.
    Axelsen TV; Holm A; Christiansen G; Birkelund S
    Vaccine; 2011 Apr; 29(17):3260-9. PubMed ID: 21371581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer's Disease.
    Hansen HH; Fabricius K; Barkholt P; Niehoff ML; Morley JE; Jelsing J; Pyke C; Knudsen LB; Farr SA; Vrang N
    J Alzheimers Dis; 2015; 46(4):877-88. PubMed ID: 25869785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of the bioactivity of antibodies against beta-amyloid peptide in vitro and in vivo.
    Mohajeri MH; Gaugler MN; Martinez J; Tracy J; Li H; Crameri A; Kuehnle K; Wollmer MA; Nitsch RM
    Neurodegener Dis; 2004; 1(4-5):160-7. PubMed ID: 16908985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Critical role of cPLA2 in Aβ oligomer-induced neurodegeneration and memory deficit.
    Desbène C; Malaplate-Armand C; Youssef I; Garcia P; Stenger C; Sauvée M; Fischer N; Rimet D; Koziel V; Escanyé MC; Oster T; Kriem B; Yen FT; Pillot T; Olivier JL
    Neurobiol Aging; 2012 Jun; 33(6):1123.e17-29. PubMed ID: 22188721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic nicotine restores normal Aβ levels and prevents short-term memory and E-LTP impairment in Aβ rat model of Alzheimer's disease.
    Srivareerat M; Tran TT; Salim S; Aleisa AM; Alkadhi KA
    Neurobiol Aging; 2011 May; 32(5):834-44. PubMed ID: 19464074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increase in presenilin 1 (PS1) levels in senescence-accelerated mice (SAMP8) may indirectly impair memory by affecting amyloid precursor protein (APP) processing.
    Kumar VB; Franko M; Banks WA; Kasinadhuni P; Farr SA; Vyas K; Choudhuri V; Morley JE
    J Exp Biol; 2009 Feb; 212(Pt 4):494-8. PubMed ID: 19181896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease.
    Barghorn S; Nimmrich V; Striebinger A; Krantz C; Keller P; Janson B; Bahr M; Schmidt M; Bitner RS; Harlan J; Barlow E; Ebert U; Hillen H
    J Neurochem; 2005 Nov; 95(3):834-47. PubMed ID: 16135089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential susceptibility following beta-amyloid peptide-(1-40) administration in C57BL/6 and Swiss albino mice: Evidence for a dissociation between cognitive deficits and the glutathione system response.
    Prediger RD; Franco JL; Pandolfo P; Medeiros R; Duarte FS; Di Giunta G; Figueiredo CP; Farina M; Calixto JB; Takahashi RN; Dafre AL
    Behav Brain Res; 2007 Feb; 177(2):205-13. PubMed ID: 17194489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunotherapy against APP beta-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain abeta levels.
    Rakover I; Arbel M; Solomon B
    Neurodegener Dis; 2007; 4(5):392-402. PubMed ID: 17536186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of acute and repeated oroxylin A treatments on Abeta(25-35)-induced memory impairment in mice.
    Kim DH; Kim S; Jeon SJ; Son KH; Lee S; Yoon BH; Cheong JH; Ko KH; Ryu JH
    Neuropharmacology; 2008 Oct; 55(5):639-47. PubMed ID: 18620712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunization with either prion protein fragment 95-123 or the fragment-specific antibodies rescue memory loss and neurodegenerative phenotype of neurons in olfactory bulbectomized mice.
    Bobkova NV; Medvinskaya NI; Kamynina AV; Aleksandrova IY; Nesterova IV; Samokhin AN; Koroev DO; Filatova MP; Nekrasov PV; Abramov AY; Leonov SV; Volpina OM
    Neurobiol Learn Mem; 2014 Jan; 107():50-64. PubMed ID: 24239620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effects of xanthoceraside on learning and memory impairment induced by Abeta(25-35) in mice.
    Chi TY; Wang LH; Qu C; Yang BZ; Ji XF; Wang Y; Okuyama T; Yoshihito O; Zou LB
    J Asian Nat Prod Res; 2009 Dec; 11(12):1019-27. PubMed ID: 20183271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. JD-30, an active fraction extracted from Danggui-Shaoyao-San, decreases β-amyloid content and deposition, improves LTP reduction and prevents spatial cognition impairment in SAMP8 mice.
    Hu ZY; Liu G; Cheng XR; Huang Y; Yang S; Qiao SY; Sun L; Zhou WX; Zhang YX
    Exp Gerontol; 2012 Jan; 47(1):14-22. PubMed ID: 22063923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving memory and decreasing cognitive impairment in Tg-APPswe/PSEN1dE9 mice with Aβ3-10 repeat fragment plasmid by reducing Aβ deposition and inflammatory response.
    Ma Y; Li Y; Zong LX; Xing XN; Zhang WG; Cao YP
    Brain Res; 2011 Jul; 1400():112-24. PubMed ID: 21658683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imipramine, in part through tumor necrosis factor alpha inhibition, prevents cognitive decline and beta-amyloid accumulation in a mouse model of Alzheimer's disease.
    Chavant F; Deguil J; Pain S; Ingrand I; Milin S; Fauconneau B; Pérault-Pochat MC; Lafay-Chebassier C
    J Pharmacol Exp Ther; 2010 Feb; 332(2):505-14. PubMed ID: 19889791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a proteolytically stable retro-inverso peptide inhibitor of beta-amyloid oligomerization as a potential novel treatment for Alzheimer's disease.
    Taylor M; Moore S; Mayes J; Parkin E; Beeg M; Canovi M; Gobbi M; Mann DM; Allsop D
    Biochemistry; 2010 Apr; 49(15):3261-72. PubMed ID: 20230062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urine formaldehyde level is inversely correlated to mini mental state examination scores in senile dementia.
    Tong Z; Zhang J; Luo W; Wang W; Li F; Li H; Luo H; Lu J; Zhou J; Wan Y; He R
    Neurobiol Aging; 2011 Jan; 32(1):31-41. PubMed ID: 19879019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ferulic acid inhibits the transition of amyloid-β42 monomers to oligomers but accelerates the transition from oligomers to fibrils.
    Cui L; Zhang Y; Cao H; Wang Y; Teng T; Ma G; Li Y; Li K; Zhang Y
    J Alzheimers Dis; 2013; 37(1):19-28. PubMed ID: 23727899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.